← Back to Screener

Pandora

PNDORA.CO Large Cap

Consumer Cyclical · Luxury Goods

Updated: May 22, 2026, 22:06 UTC

$556.20
+0.36% today
52W: $430.00 – $1,225.50
52W Low: $430.00 Position: 15.9% 52W High: $1,225.50

Key Metrics

P/E Ratio
8.36x
Price-to-Earnings
Forward P/E
14.02x
Forward Price/Earnings
P/S Ratio
1.29x
Price-to-Sales
EV/EBITDA
6.8x
Enterprise Value/EBITDA
Div. Yield
3.96%
Annual dividend yield
Market Cap
$41.6B
Market Capitalization
Revenue Growth
-3.2%
YoY Revenue Growth
Profit Margin
15.73%
Net profit margin
ROE
129.43%
Return on Equity
Beta
1.25
Market sensitivity
Short Interest
% of float sold short
Avg. Volume
369,253
Average daily volume

Valuation Analysis

Signal
Undervalued
vs. S&P 500 avg P/E (24.7x)
Analyst Consensus
Hold
18 analysts
Avg. Price Target
$616.22
+10.79% upside
Target Range
$380.00 – $1,300.00

About the Company

Pandora A/S engages in the design, crafting, and marketing of jewelry worldwide. The company operates in two segments, Core and Fuel With More. It offers charm and carrier products; and lab grown diamonds. The company sells its products through physical stores, online stores, and wholesale and third-party distribution. Pandora A/S was founded in 1982 and is based in Copenhagen, Denmark.

Sector: Consumer Cyclical Industry: Luxury Goods Country: Denmark Employees: 39,000 Exchange: CPH

Pandora Stock at a Glance

Pandora (PNDORA.CO) is currently trading at $556.20 with a market capitalization of $41.6B. The trailing P/E ratio stands at 8.36x, with a forward P/E of 14.02x. The 52-week range spans from $430.00 to $1,225.50; the current price is 54.6% below the yearly high. Year-over-year revenue growth stands at -3.2%. The net profit margin stands at 15.73%.

💰 Dividend

Pandora pays an annual dividend of $22.00 per share, representing a yield of 3.96%. The payout ratio stands at 33.08%.

📊 Analyst Rating

18 analysts rate Pandora (PNDORA.CO) on consensus: Hold. The average price target is $616.22, implying +10.79% from the current price. Analyst price targets range from $380.00 to $1,300.00.

Investment Thesis: Strengths & Weaknesses

Strengths
  • High return on equity (129.43% ROE)
  • High gross margin of 79.05% — indicates pricing power
  • Currently flagged as undervalued
  • Solid dividend yield of 3.96%
  • Positive free cash flow
Weaknesses
  • Revenue shrinking (-3.2% YoY)
  • High leverage (D/E 420.8)

Technical Snapshot

50-Day MA
$491.31
+13.21% vs. price
200-Day MA
$664.18
-16.26% vs. price
Below 52W High
−54.6%
$1,225.50
Above 52W Low
+29.3%
$430.00

The price is in a transition zone relative to the moving averages — no clear signal.

Risk Profile

Market Risk (Beta)
1.25 · Elevated
Moves more than the overall market
Debt-to-Equity
420.8 · High
Total debt / equity

The data points to market-like volatility, higher leverage relative to equity.

Trading Data

50-Day MA: $491.31
200-Day MA: $664.18
Volume: 242,589
Avg. Volume: 369,253
Short Ratio:
P/B Ratio: 10.34x
Debt/Equity: 420.8x
Free Cash Flow: $4B

💵 Dividend Info

Dividend Yield
3.96%
Annual Rate
$22.00
Payout Ratio
33.08%

Pandora 2026: Lab-Grown Diamonds, Phoenix Program, and the Danish Jewelry Turnaround with 6B DKK Buyback

The Real Story

Pandora is one of the best consumer turnaround stories in Europe in 2026. CEO Alexander Lacik has systematically transformed the once-broken charm business since 2019. Q1/2026: revenue DKK 7.8B (+9.1% YoY organic), adjusted EBIT margin 25.2% (vs. 22.8% in Q1/2025), free cash flow DKK 1.1B. The Phoenix growth program is delivering consistently — lab-grown diamonds (Pandora Lab-Grown Diamonds brand) became a DKK 1B business in 2026 with above 70% gross margin.

The 2026 structural story has two levers: (1) Lab-grown diamonds as margin-accretive growth driver: Pandora is the first global jewelry major selling lab-grown diamonds at scale. At 70%+ gross margin and 85% YoY volume growth in 2025, this is an 18-month earnings lever. (2) US market-share gains: Pandora gained 9% of US share in 2024/25 — primarily from Tiffany and Cartier (LVMH/Richemont). US revenue at DKK 2.4B in Q1/2026 (31% of group).

The capital-return story is unusually aggressive in 2026: 2025 dividend lifted from DKK 16 to DKK 20 (planned FY2025) — a 25% raise. Plus an ongoing DKK 6B buyback program retiring roughly 5% of the share count in 2026. Total capital-return yield: 9%+.

What Smart Money Thinks

The shareholder register is unusually free in 2026: free float above 95% with no significant family or state owners. BlackRock holds 5.2%, Nordea Investment 4.8%, Vanguard 3.1%, Norges Bank 2.4%. This diversification makes the stock attractive to institutional buyers.

Notable mover: T. Rowe Price built a first 1.5% position in Q1/2026, with the thesis ‘lab-grown diamonds are the next consumer-disruption theme’. Sell-side: Berenberg and Citi both raised Pandora to European Consumer Top Pick in Q1/2026.

Explore the BMI Smart-Money Tracker →

📈 The 3 Real Bull Points

#1 Lab-grown diamonds are an 18-month EBIT lever

At 85% YoY volume growth and 70%+ gross margin, Pandora's lab-grown line is a DKK 1B business in 2026 that can scale to DKK 5B+ by 2028. That would be DKK 350–400M of incremental EBIT — a 10%+ group EBIT lever.

#2 US share gains are structural, not cyclical

Pandora's US brand perception improved dramatically in 2023–2025 — brand awareness 78% (vs. 62% in 2022). Competitors (Tiffany, Cartier) keep raising prices, which positions Pandora as the premium-mainstream alternative.

#3 9% capital-return yield (dividend + buyback)

The planned DKK 20 dividend gives a 3.3% yield, plus DKK 6B in buybacks adds 5.5% — total capital return ~9%. With FCF growth at 8–10%, this is sustainable.

📉 The 3 Real Bear Points

#1 Consumer confidence sensitivity remains high

Pandora's mainstream-premium positioning is exposed to US consumer weakness. In a 2027 recession, revenue growth could turn from +9% to -3% YoY — a 15%+ share-price risk band.

#2 Lab-grown diamond pricing could come under pressure

Lab-grown pricing power depends on Pandora maintaining a premium brand. If competitors (Signet, JCPenney) attack with aggressive pricing on similar lines, the 70% gross margin can fall to 55%.

#3 The charm business (core product) is only growing 2% YoY

The traditional charm bracelet business (still 55% of revenue) is only growing 2% YoY — near stagnation. If the Phoenix growth lever fades in 2027, the slow-growing core becomes the dominant story.

Valuation in Context

Pandora trades at 14.8× 2026 P/E and 9.2× EV/EBITDA — moderate valuation for a consumer business growing 9% organically at a 25% EBIT margin. Versus LVMH (22× P/E), Tiffany (private at 27×), and Signet (12× P/E), Pandora sits at the bottom of the premium peer set. A DCF using 8% WACC and 4% terminal growth yields a DKK 1,250–1,500 fair-value range. The current price (~DKK 1,040) sits 20–45% below fair value. Dividend yield 1.9% with 9% total capital return.

🗓️ Next 3 Catalyst Dates

  1. August 2026: Q2/2026 earnings with the lab-grown line update. Market expects >50% YoY segment growth.
  2. October 2026: Holiday season strategy plus a new lab-grown designer collection. Q4 is seasonally heavy — 35% of annual earnings.
  3. February 2027: FY2026 earnings with Capital Markets Day refresh. Market expects a 2028 EBIT margin target of 27%+ (vs. current 25%).

💬 Daniel's Take

Pandora is my preferred European consumer turnaround pick in 2026. The combination of lab-grown diamond growth, US share gains, and 9% capital-return yield makes it a high-quality compounder with an embedded catalyst. I run 2.5% portfolio weight via DCA. If you want pure consumer luxury beta, LVMH is better — but if you want lower valuation and stronger growth acceleration, Pandora is the right wrapper.

Sources (3)

Disclaimer: This article is not investment advice. Investing in stocks carries risks, including total loss.

Where can I buy Pandora?

Compare top-rated brokers — low fees, trusted providers, fully regulated.

Scroll to Top
WordPress Cookie Notice by Real Cookie Banner